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Introduction
Age [3, 9, 18, 22, 24, 31, 32, 35, 36], atrial fibrillation
[8, 18, 21, 22, 26, 33, 38] (AF) and stroke severity
[1, 8, 18, 22, 32, 35, 36] are the most powerful pre-
dictors of in-hospital death for patients with ische-
mic stroke (IS). Other factors such as female gender
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j Abstract Background Atrial
fibrillation (AF) is considered a
predictive factor of poor clinical
outcome in patients with an ische-
mic stroke (IS). This study ad-
dressed whether the impact of AF
on the in-hospital mortality after
first ever IS is different according to
the patient’s gender.Methods We
prospectively studied 1678 patients
with first ever IS consecutively
admitted to two University Hospi-
tals. We recorded demographic
data, vascular risk factors, and the
stroke severity (NIHSS) at admis-
sion analyzing their impact on the
in-hospital mortality and on the
combinedmortality-dependency at
discharge using a Cox proportional
hazards model. Two variable
interactions between those factors
independently related to in-hospi-
tal mortality and combined mor-
tality-dependency at discharge
were tested. Results Overall in-
hospital mortality was 11.3%. Cox
proportional hazards model
showed that NIHSS at admission
(HR: 1.178 [95% CI 1.149–1.207]),
age (HR: 1.044 [95% CI 1.026–
1.061]), AF (HR: 1.416 [95% CI
1.048–1.913]), male gender (HR:
1.853 [95% CI 1.323–2.192) and
ischemic heart disease (HR: 1.527
[95% CI 1.063–2.192]) were inde-
pendent predictors of in-hospital
mortality. A significant interaction
between gender and AF was found
(p = 0.017). Data were stratified by
gender, showing that AF was an
independent predictor of poor
outcome just for woman (HR: 2.183
[95% CI 1.403–3.396]; p < 0.001).
The independent predictors of
combined mortality-disability at
discharge wereNIHSS at admission
(HR: 1.052 [95% CI 1.041–1.063]),
age (HR: 1.011 [95% CI 1.004–
1.018]), AF (HR: 1.197 [95% CI
1.031–1.390]), ischemic heart dis-
ease (HR: 1.222 [95% CI 1.004–
1.488]), and smoking (HR: 1.262
[95% CI 1.033–1.541]).
Conclusions The impact of AF is
different in the two genders and
appears as a specific ischemic
stroke predictor of in-hospital
mortality just for women.
j Key words: ischemic stroke
atrial fibrillation Æ gender differen-
ces Æ outcome
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38], hyperglycemia [29, 37], congestive heart failure
[24, 29], previous stroke [18], previous ex-smoker
status [38], body temperature [27, 36], high and low
admission blood pressure-values [7, 34], elevated
pulse pressure [5], and early impairment in con-
sciousness [10] have also been reported. In recent
years, there has been an increasing interest in ana-
lyzing stroke characteristics and clinical outcome in
different subgroups of patients such as women
[4, 28] and older patients [3, 22]. Nevertheless,
specific data on early mortality predictors in these
populations are scarce. In this way, some studies
have suggested that factors influencing early death
after acute stroke are different in older patients from
those in younger ones as well as in men versus
women [18], and that the impact of AF could differ
in the two genders. Information about these inter-
relations and their final real impact on outcome
would be of interest in estimating more accurately
those factors influencing early mortality after acute
IS. The aim of our study was to assess if in-hospital
mortality and functional dependence at hospital
discharge differ between male and female patients
with IS and AF.
Methods
We analyzed 1860 consecutive patients with first ever acute IS
admitted to two University Hospitals. IS diagnosis was performed
following the World Health Organization definition of stroke [2].
All patients were assessed within 24 hours of stroke. Cases with a
diagnosis of transient ischemic attack, subarachnoid hemorrhage,
subdural or extradural hemorrhage, brain injury resulting from
trauma or neoplastic causes, or those with a previous clinical stroke
were excluded. From the total of 1860 patients registered, 97 were
excluded from further analyses because of incomplete data, 85
additional patients were not included in the analysis because they
were treated with tPA (n = 51) or were included in neuroprotective
pharmacological trials (n = 34). Finally, 1678 patients were studied.
Data were obtained for patients, via their next of kin, or from
medical records. All patients fulfilled a clinical protocol which in-
cluded demographic data, previous antiplatelet or anticoagulant
treatment, vascular risk factors (arterial hypertension, diabetes, AF,
previous ischemic heart disease, and current smoking), the stroke
severity measured by the National Institutes of Health Stroke Score
(NIHSS) [16, 17] at admission, and the combined mortality-
dependency status at discharge using the modified Rankin Scale
(mRS). The diagnosis of cerebral infarction was confirmed in all
patients by brain computed tomography or magnetic resonance
imaging. We considered AF when it was documented by two EKGs
or when it was detected during hospitalization. The primary out-
come of the study was early death, defined as in-hospital mortality.
j Statistical analysis
We analyzed the impact of age, gender, previous antiplatelet or
anticoagulant treatment, arterial hypertension, diabetes, AF,
ischemic heart disease, current smoking and NIHSS on in-hospital
mortality. Qualitative variables were recorded as percentages and
quantitative variables as mean and standard deviations. The t-test
was used to test differences in continuous variables and the Chi
square test for those in proportions. The Cox proportional hazards
model was performed to estimate hazard ratios (HR) and the
resulting 95% CI of predictors of in-hospital mortality. Length of
acute care hospital admission was defined as survival time. In-
hospital death was defined as outcome event. Patients were cen-
sored if they were alive at discharge. In the first step, we performed
a univariate analysis to determine which variables were related to
an increase of in-hospital mortality. Then, by means of the Cox
proportional hazards model, we analyzed the independent predic-
tors of in-hospital mortality after controlling for possible con-
founding variables according to the results of the univariate
analysis (variables that reached a p < 0.15 were included in the
regression model). To evaluate gender differences in the prediction
of in-hospital mortality, gender was included in the model. Gender,
previous antithrombotic treatment, arterial hypertension, diabetes,
AF, ischemic heart diseases and current smoking were included as
qualitative variables. Age and NIHSS values were included as
quantitative variables. Using the same methodology, we also ana-
lyzed the predictors of combined mortality-dependency at dis-
charge after dichotomizing the series into two groups: non-disabled
patient (mRS from 0 to 2) and death-disabled patients (mRS from 3
to 6). Possible two variable interactions between those factors
independently related to in-hospital mortality and for combined
mortality-dependency were also evaluated. All tests were 2-tailed,
and significance was determined at a a level of 0.05. Statistical
analyses were performed with the SPSS 11.5 software package.
j Ethics
The information of the study was collected from the prospective
clinical protocols of both participants’ hospitals, which fulfilled the
local ethical guidelines. The identity of the individual patients was
completely anonymous. Therefore, no specific informed consent
was signed by patients.
Results
Demographic and baseline data of the patients and
the results of the univariate analysis of factors related
to in-hospital mortality are summarized in Table 1.
Median length of hospitalization was 11 (7,16) days.
Overall in-hospital mortality was 11.3% (10.9% in
men and 11.6% in women). When mortality was
analysed by age subgroups (< or ‡ 75 years), it was
lower in women for both age groups (4.9 % in
< 75 years; 16.1% in ‡ 75 years) compared with men
(5.7% in < 75 years and 19.9% in ‡ 75 years, p = ns).
Kaplan Meier test showed that mortality at 30-day was
21.3 % (95% CI: 17.3–25.4).
Predictors of in-hospital mortality by Cox pro-
portional hazards model are showed in Table 2.
Current smoking (HR: 1.059, [95% CI: 0.700–1.604],
p = 0.785), and previous antiplatelet treatment (HR:
1.089, [95% CI: 0.769–1.543], p = 0.631) did not reach
statistical significance. The two variable interactions
between independent predictors of in-hospital mor-
tality showed no significant interaction between age
and AF (p = 0.789), ischemic heart disease and gen-
der (p = 0.917), age and gender (p = 0.789), and age
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and NIHSS (p = 0.731). However, a significant inter-
action between gender and AF was found (p = 0.017).
Therefore, data were stratified by gender. The results
of the Cox proportional hazards model is shown in
Table 3. Previous antiplatelet treatment (HR 0.934,
[95% CI: 0.568–1.536], p = 0.788, for women; HR:
1.164, [95% CI: 0.703–1.929], p = 0.555 for men);
ischemic heart disease (HR 1.457, [95% CI: 0.867–
2.450], p = 0.156, for women; HR: 1.605, [95% CI:
0.952–2.704], p = 0.076 for men) and current smok-
ing (HR 2.486, [95% CI: 0.668–10.872], p = 0.226, for
women; HR: 0.822, [95% CI: 0.532–1.271], p = 0.378
for men) did not reach statistical significance.
According to the combined mortality-dependency
at discharge, 831 patients had a mRS from 3 to 6, and
847 had a mRS from 0 to 2. The univariate analysis of
factors related to combined mortality-dependency at
discharge is summarized in Table 4. Predictors of
combined mortality-dependency at discharge by Cox
proportional hazards model are shown in Table 5.
Arterial hypertension (HR 1.046 [95% CI: 0.905–
1.210]; p = 0.543) and previous antiplatelet treatment
(HR 0.931 [95% CI: 0.779–1.114]; p = 0.436) did not
reach statistical significance in the multivariante
analysis. In addition, gender (HR 1.097 [95% CI:
0.930–1.293]; p = 0.273), did not reach statistical
significance, so data were not stratified and analyzed
by gender.
Discussion
Our study found that, in a prospective population
with IS assessed in two centres, stroke severity at
admission, ischemic heart disease, male gender, older
age, and AF were independent predictors for in-hos-
pital death. Stroke severity at admission measured by
the NIHSS was the most powerful predictor of early
mortality [1, 14, 25, 36], with a HR of 1.178 [95% CI:
1.149–1.207] for each further NIHSS point at admis-
sion. Additionally, the HR of early death for patients
with past ischemic heart disease increased to 1.527
[95% CI: 1.063–2.192]. The deleterious impact of
previous ischemic heart disease in the early mortality
after stroke has not been previously described.
Male gender, with a HR of 1.853 [95% CI: 1.323–
2.192], was also an independent predictor of early
death. This result contrasted in our series with the
percentage of women who died during the hospital-
ization period, which was slightly higher than for
men. This fact lead us to analyze the distribution of
deaths according to age (< or ‡ 75 years) and we
found that, although in the whole series the mortality
was higher in women, the percentage of men who died
was higher in the group of < 75 years as well as in the
group of ‡ 75 years (see Results section). Interest-
ingly, 67% of men’s mortality occurs in patients
‡ 75 years whereas, in women, 83.3% of mortality
occurs in this age group. This finding has been pre-
viously described as a higher age-specific rate of
stroke death in women [6], and can explain the higher
crude mortality rate in women. Most studies that have
analyzed the differences in stroke morbidity/mortality
in both genders have usually found a higher mortality
or disability rate in women [1, 4, 6, 12, 18, 19, 28, 39],









Mean age (SD), years 72.8 (12.3) 80.6 (9.1) 71.8 (12.3) 0.0001 (*)
Men (%) 852 (50.8) 93 (10.9) 759 (89.1)
Women (%) 826 (49.8) 96 (11.6) 730 (88.4) 0.647 [0.93 (0.68–1.28)]
Arterial hypertension (%) 1022 (60.9) 116 (61.3) 906 (60.8) 0.860 [1.02 (0.74–1.41)]
Diabetes mellitus (%) 500 (29.8) 61 (32.3) 439 (29.5) 0.433 [1.14 (0.81–1.60)]
Ischemic heart disease (%) 247 (14.7) 41 (21.7) 206 (13.8) 0.004 (*) [1.73 (1.16–2.55)]
Atrial fibrillation (%) 523 (31.2) 105 (55.6) 418 (28.1) 0.0001 (*) [3.20 (2.33–4.41)]
Current smoking (%) 467 (27.8) 40 (21.2) 427 (28.7) 0.030 (*) [0.69 (0.46–0.96)]
Previous antiplatelet treatment (%) 335 (19.9) 49 (25.9) 286 (19.2) 0.030 (*) [1.47 (1.02–2.12)]
Previous anticoagulant treatment (%) 77 (5.9) 12 (4.2) 65 (6.1) 0.22 [0.67 (0.36–1.27)]
NIHSS at admission, (median, q1–q3) 7 (3,16) 20 (17.5,21) 3 (6,12) 0.0001 (*)
Mean values; SD values in parentheses.
Median values, Quartile 1–3: quartile values in parentheses.
(*) Variables included in the Cox proportional hazards model.
Table 2 Cox proportional hazards model. Independent predictors for
in-hospital mortality
HR 95%CI p
NIHSS 1.178 1.149–1.207 0.0001
Age 1.044 1.026–1.061 0.0001
AF 1.416 1.048–1.913 0.023
Male gender 1.853 1.323–2.192 0.0001
Ischemic heart disease 1.527 1.063–2.192 0.022
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probably due to an analysis based on the crude
mortality ratios observed in both genders.
In our study, an older age was another indepen-
dent poor predictor factor, a fact supported by pre-
vious reports [3, 9, 18, 22, 31, 32]. Interestingly, a
recent study [23] showed that mortality in older pa-
tients was higher when AF was present (HR: 1.39 for
30-day mortality). In the same way, we found that AF
played an important role for stroke outcome since the
presence of AF implied a HR of in-hospital death of
1.416 [95% CI: 1.048–1.913]. The higher risk of early
death observed in acute IS patients with AF [19, 20,
30] and the deleterious impact of AF on stroke out-
come has been extensively reported [8, 18, 22, 26, 33,
38]. The gender-specific effect of AF on the risk of
stroke and cardiovascular death was analyzed in the
Copenhagen City Heart Study [15] during a follow-up
of 5 years. After adjustment for age and co-morbidity,
the effect of AF on the risk of stroke was 4.6-fold
greater in women than in men, and the independent
effect of AF on cardiovascular mortality rate was
2.5-fold greater in women than in men, suggesting
that AF is a much more pronounced risk factor for
stroke and cardiovascular death in women than in
men. The German Stroke Registers Study Group [18]
has recently reported substantial differences on the
impact of comorbid conditions on early outcome for
men and women. In women, a higher age, the severity
of stroke defined by the number of neurological def-
icits, and AF (HR: 1.3; [95% CI: 1.0–1.6]) were inde-
pendent predictors for in-hospital death. Meanwhile,
in men, diabetes and previous stroke had a significant
negative impact on early outcome in addition to the
factors identified for women. Our results (Table 3)
supports the notion that gender differences exist
during the acute stroke phase. Whereas the impact of
NIHSS, and age was similar in both gender, we found
a clear difference on the impact of AF for women and
men. After adjustment for confounders factors, AF
was an independent predictor of early death just for
women, with a HR of 2.183 [95% CI: 1.403–3.396],
whereas in men, AF has not impact on early mortality.
Table 3 Cox proportional hazards model. Independent predictors for in-hospital mortality according to gender
Women (n = 826) Men (n = 852)
HR 95% CI p HR 95% CI p
NIHSS 1.225 1.169–1.283 0.0001 1.165 1.129–1.202 0.0001
AF 2.183 1.403–3.396 0.001 0.904 0.579–1.411 0.656
Age 1.040 1.015–1.067 0.002 1.053 1.029–1.078 0.0001
Table 4 Univariate analysis of patients according to combined mortality disability at discharge after first ever ischemic stroke
Total cases
(n = 1678)
mRS 3 to 6 at discharge
(n = 831)
mRS 0 to 2 at discharge
(n = 847)
P value (OR 95%CI)
Mean age (SD), years 72.8 (12.3) 74.4 (11.2) 69.3 (12.3) 0.0001 (*)
Men (%) 852 (50.8) 356 (41.8) 496 (58.2)
Women (%) 826 (49.8) 475 (57.5) 351 (42.5) 0.0001 (*) 0.530 (0.430–0.650)
Arterial hypertension (%) 1022 (60.9) 534 (64.3) 488 (57.6) 0.005 (*) 1.323 (1.086–1.610)
Diabetes mellitus (%) 500 (29.8) 254 (30.6) 246 (29.0) 0.496 1.075 (0.872–1.326)
Ischemic heart disease (%) 247 (14.7) 133 (16.0) 114 (13.5) 0.141 (*) 1.225 (0.935–1.606)
Atrial fibrillation (%) 523 (31.2) 317 (38.1) 206 (24.3) 0.0001 (*) 1.919 (1.555–2.368)
Current smoking (%) 467 (27.8) 172 (20.7) 295 (34.8) 0.0001 (*) 0.492 (0.395–0.613)
Previous antiplatelet treatment (%) 335 (20.0) 180 (21.7) 155 (18.3) 0.085 (*) 1.234 (0.971–1.569)
Previous anticoagulant treatment (%) 77 (4.6) 43 (5.2) 34 (4.0) 0.256 1.305 (0.823–2.968)
NIHSS at admission, (median, q1–q3) 7 (3,16) 13 (8,18) 3 (2,6) 0.0001 (*)
Mean values; SD values in parentheses
Median values; Quartile 1–3: quartile values in parentheses
(*) Variables included in the Cox proportional hazards model
Table 5 Cox proportional hazards model. Independent predictors for
combined mortality-disability at discharge in patients after first-ever ischemic
stroke
HR 95%CI p
NIHSS 1.052 1.041–1.063 0.0001
Age 1.011 1.004–1.018 0.002
AF 1.197 1.031–1.390 0.019
Smoking 1.262 1.033–1.541 0.023
Ischemic heart disease 1.222 1.004–1.488 0.045
1487
There is no clear explanation for the specific delete-
rious role of AF for women, but there are some evi-
dences suggesting that AF has a greater impact on
women gender. A recent study has demonstrated that
female sex is an independent risk factor for throm-
boembolic complications in patients with AF [13].
Interestingly, AF is associated with higher levels of
prothrombotic status and endothelial dysfunction,
but sex-related differences in these factors have not
been demonstrated [13].
The combined analysis of mortality-dependency at
hospital discharge, showed similar predictors to those
observed for in-hospital mortality analysis: NIHSS
(HR 1.05 [95% CI: 1.041–1.063]), age (HR 1.011 [95%
CI: 1.004–1.018]), AF (HR 1.197 [95% CI: 1.031–
1.390]), ischemic heart disease (HR 1.222 [95% CI:
1.004–1.488]) and, interestingly, current smoking (HR
1.262 [95% CI: 1.033–1.541]). A recent study has
demonstrated that smoking increased the risk of
mortality and morbidity among cardiovascular high-
risk patients participating in the HOPE trial [11].
Gender had no impact on the combined mortality-
disability at discharge.
Some limitations of our study must be mentioned.
We had no data about some interesting risk factors
such are obesity and congestive heart failure. In
addition, we excluded patients treated with t-PA and
those included in neuroprotective clinical trials in
order to get a more homogeneous series. We believe
that exclusion of such patients is justified because
patients treated in neuroprotective trials were in-
cluded in mRECT or in SAINT-I studies, and both
trials showed a possible effect- negative for mRECT
and positive for SAINT-I- on clinical outcome. Fi-
nally, patients were prospectively studied in two dif-
ferent University Hospitals, but no differences were
detected in mortality between the centres after
adjustment for gender, age, AF, ischemic heart disease
and NIHSS (HR 1.183 [95% CI 0.755–1.853];
p = 0.463).
In conclusion, our study provides evidence sug-
gesting that differences related to gender exist in the
determinants of early death after IS. Adjusted for
confounders, mortality is higher in men than in wo-
men although more women than men died during
hospitalization, and AF is an independent poor pre-
dictor just for women. All these differences provide a
more accurate tool to better predict in-hospital out-
come in patients with first ever IS.
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